RiceBran Technologies (RIBT) 10-Q 27 Oct 21 2021 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2021	Oct. 25, 2021
Document Information [Line Items]
Entity Central Index Key	0001063537
Entity Registrant Name	RiceBran Technologies
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2021
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2021
Document Transition Report	false
Entity File Number	001-36245
Entity Incorporation, State or Country Code	CA
Entity Tax Identification Number	87-0673375
Entity Address, Address Line One	25420 Kuykendahl Rd., Suite B300
Entity Address, City or Town	Tomball
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	77375
City Area Code	281
Local Phone Number	675-2421
Title of 12(b) Security	Common Stock, no par value per share
Trading Symbol	RIBT
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		50,973,654

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Revenues	$ 6,909	$ 5,160	$ 23,088	$ 19,393
Cost of goods sold	7,185	5,955	22,539	21,817
Gross profit (loss)	(276)	(795)	549	(2,424)
Selling, general and administrative expenses	1,802	1,777	5,476	6,634
Loss (gain) on disposition and involuntary conversion of property and equipment	(1)	98	5	406
Operating loss	(2,077)	(2,670)	(4,932)	(9,464)
Interest income	0	0	1	19
Interest expense	(121)	(70)	(353)	(195)
Gain on extinguishment of PPP loan	0	0	1,792	0
Other expense	(18)	(26)	(55)	(113)
Other income	3	0	3	5
Loss before income taxes	(2,213)	(2,766)	(3,544)	(9,748)
Income tax expense	0	(8)	(1)	(8)
Net loss	$ (2,213)	$ (2,774)	$ (3,545)	$ (9,756)
Loss per common share:
Basic (in dollars per share)	$ (0.05)	$ (0.07)	$ (0.08)	$ (0.24)
Diluted (in dollars per share)	$ (0.05)	$ (0.07)	$ (0.08)	$ (0.24)
Weighted average number of shares outstanding:
Basic (in shares)	47,456,842	40,824,281	46,318,804	40,279,866
Diluted (in shares)	47,456,842	40,824,281	46,318,804	40,279,866

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Net loss	$ (2,213)	$ (2,774)	$ (3,545)	$ (9,756)
Derivative financial instruments designated as cash flow hedges:
Gains (losses) arising during the period	0	43	0	(57)
Reclassification of losses realized to cost of goods sold	0	5	0	57
Net other comprehensive income	0	48	0	0
Comprehensive loss	$ (2,213)	$ (2,726)	$ (3,545)	$ (9,756)

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 6,188	$ 5,263
Accounts receivable, net of allowance for doubtful accounts of $22 and $9	2,825	2,819
Inventories	2,173	1,878
Other current assets	1,175	1,380
Total current assets	12,361	11,340
Property and equipment, net	15,680	16,367
Operating lease right-of-use assets	2,210	2,452
Goodwill	3,915	3,915
Intangible assets	573	722
Total assets	34,739	34,796
Current liabilities:
Accounts payable	911	955
Commodities payable	1,444	825
Accrued salary, wages and benefits	989	601
Accrued expenses	636	536
Operating lease liabilities, current portion	372	344
Due under insurance premium finance agreements	411	126
Due under factoring agreement	2,018	1,785
Finance lease liabilities, current portion	86	82
Long-term debt, current portion	1,436	572
Total current liabilities	8,303	5,826
Operating lease liabilities, less current portion	2,030	2,330
Finance lease liabilities, less current portion	101	113
Long-term debt, less current portion	47	3,107
Warrant liability	647	0
Total liabilities	11,128	11,376
Commitments and contingencies
Shareholders' equity:
Preferred stock, 20,000,000 shares authorized: Series G, convertible, 3,000 shares authorized, stated value $150, 150 shares and 225 shares, issued and outstanding	75	112
Common stock, no par value, 150,000,000 shares authorized, 50,166,156 shares and 45,238,087 shares, issued and outstanding	325,991	322,218
Accumulated deficit	(302,455)	(298,910)
Total shareholders' equity	23,611	23,420
Total liabilities and shareholders' equity	$ 34,739	$ 34,796

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Accounts receivable, allowance for doubtful accounts	$ 22	$ 9
Preferred stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, par value (in dollars per share)	$ 0	$ 0
Common stock, shares authorized (in shares)	150,000,000	150,000,000
Common stock, shares issued (in shares)	50,166,156	45,238,087
Common stock, shares outstanding (in shares)	50,166,156	45,238,087
Series G Preferred Stock [Member]
Preferred stock, shares authorized (in shares)	3,000	3,000
Preferred stock, stated value (in dollars per share)	$ 150	$ 150
Preferred stock, shares issued (in shares)	150	225
Preferred stock, shares outstanding (in shares)	150	225

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flow from operating activities:
Net loss	$ (3,545)	$ (9,756)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation	1,821	1,804
Amortization	150	173
Stock and share-based compensation	840	817
Loss on diposition and involuntary conversion of property and equipment	5	406
Gain on extinguishment of PPP loan	(1,792)	0
Other	67	(18)
Changes in operating assets and liabilities:
Accounts receivable	(18)	1,360
Inventories	(295)	(767)
Accounts payable and accrued expenses	594	(651)
Commodities payable	619	(275)
Other	(431)	(321)
Net cash used in operating activities	(1,985)	(7,228)
Cash flows from investing activities:
Purchases of property and equipment	(1,187)	(1,060)
Proceeds from insurance on involuntary conversion	638	250
Proceeds from sale of property	0	15
Net cash used in investing activities	(549)	(795)
Cash flows from financing activities:
Advances on factoring agreement	22,135	20,584
Payments on factoring agreement	(21,970)	(20,663)
Advances on insurance premium finance agreements	962	802
Payments on insurance premium finance agreements	(677)	(591)
Advances on long-term debt and finance lease liabilities	0	2,792
Payments on long-term debt and finance lease liabilities	(534)	(124)
Proceeds from issuances of common stock and warrants, net of costs	3,372	657
Proceeds from common stock warrant exercises	171	12
Net cash provided by financing activities	3,459	3,469
Net change in cash and cash equivalents	925	(4,554)
Cash and cash equivalents, beginning of period	5,263	8,444
Cash and cash equivalents, end of period	6,188	3,890
Net change in cash and cash equivalents	925	(4,554)
Supplemental disclosures:
Cash paid for interest	267	126
Cash paid for income taxes	$ 15	$ 7

Note 1 - Basis of Presentation

Note 1 - Basis of Presentation	9 Months Ended
	Sep. 30, 2021
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	NOTE 1. In the opinion of management, the accompanying unaudited condensed consolidated financial statements (interim financial statements) of RiceBran Technologies and its subsidiaries were prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and the rules and regulations of the Securities and Exchange Commission (the "SEC") for reporting on Form 10 not These interim financial statements should be read in conjunction with the consolidated audited financial statements and notes thereto in our Annual Report on Form 10 December 31, 2020, The results reported in these interim financial statements are not

Note 2 - Business

Note 2 - Business	9 Months Ended
	Sep. 30, 2021
Notes to Financial Statements
Nature of Operations [Text Block]	NOTE 2. We are a specialty ingredient company focused on the development, production, and marketing of products derived from traditional and ancient small grains. We create and produce products utilizing proprietary processes to deliver improved nutrition, ease of use, and extended shelf-life, while addressing consumer demand for all natural, non-GMO and organic products. We believe our products are valuable alternatives to traditional food ingredients. Notably, we apply our proprietary technologies to convert raw rice bran into stabilized rice bran ("SRB"), and high value-added derivative products including: RiBalance, a rice bran nutritional package derived from SRB; RiSolubles, a nutritious, carbohydrate and lipid rich fraction of RiBalance; RiFiber, a fiber rich insoluble derivative of RiBalance and ProRyza, a rice bran protein-based product; as well as a variety of other valuable derivatives extracted from these core products. In granular form, SRB is an ingredient used in products for human and animal consumption. We believe SRB has certain qualities that make it more attractive than ingredients based on the by-products of other agricultural commodities, including corn, soybeans, wheat, and yeast. Our SRB products and SRB derivatives support the production of healthy, natural, hypoallergenic, gluten free, and non-genetically modified ingredients and supplements for use in meats, baked goods, cereals, coatings, health foods, and high-end animal nutrition. Our target customers are food and animal nutrition manufacturers, wholesalers and retailers, both domestically and internationally. We manufacture and distribute SRB from four locations: two facilities located within supplier-owned rice mills in Arbuckle and West Sacramento, California; one company-owned facility in Mermentau, Louisiana; and our own rice mill in Wynne, Arkansas. At our Dillon, Montana facility, we produce SRB-based products and derivatives through proprietary processes. Our rice mill in Wynne, Arkansas also supplies grades U.S. No. 1 No. 2

Note 3 - Summary of Significant

Note 3 - Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2021
Notes to Financial Statements
Significant Accounting Policies [Text Block]	NOTE 3. Recent accounting standards not The following discusses the accounting standard(s) not In June 2016, ASU No. 2016 13 Credit Losses (Topic 326 Measurement of Credit Losses on Financial Instruments 2023 January 1, 2023. not Recently adopted accounting standards In August 2020, ASU 2020 06, Debt with Conversion and Other Options (Subtopic 470 20 Contracts in Entity s Own Equity (Subtopic 815 40 815 40 25. 2020 06 January 1, 2021, no

Note 4 - Cash and Cash Equivale

Note 4 - Cash and Cash Equivalents	9 Months Ended
	Sep. 30, 2021
Notes to Financial Statements
Cash and Cash Equivalents Disclosure [Text Block]	NOTE 4. As of September 30, 2021, three We have cash on deposit in excess of federally insured limits at a bank. We do not

Note 5 - Accounts Receivable an

Note 5 - Accounts Receivable and Revenues	9 Months Ended
	Sep. 30, 2021
Notes to Financial Statements
Accounts Receivable and Revenues [Text Block}	NOTE 5. Amounts billed and due from our customers are classified as accounts receivables on our consolidated balance sheets and require payment on a short-term basis. Invoices are generally issued at the point control transfers and substantially all of our invoices are due within 30 120 30 Our accounts receivable potentially subject us to significant concentrations of credit risk. Revenues and accounts receivable from significant customers (customers with revenue or accounts receivable in excess of 10% Customer A B C D E % of revenues, three months ended September 30, 2021 21 % 9 % 7 % 5 % 2 % % of revenues, three months ended September 30, 2020 - % - % 6 % 12 % 4 % % of revenues, nine months ended September 30, 2021 10 % 11 % 11 % 5 % 2 % % of revenues, nine months ended September 30, 2020 1 % 3 % 11 % 10 % 3 % % of accounts receivable, as of September 30, 2021 15 % 4 % 9 % 8 % 6 % % of accounts receivable, as of December 31, 2020 10 % 7 % 1 % 17 % 10 % The following table presents revenues by geographic area shipped to (in thousands). Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 United States $ 6,450 $ 4,714 $ 21,867 $ 18,214 Other countries 459 446 1,221 1,179 Revenues $ 6,909 $ 5,160 $ 23,088 $ 19,393

Note 6 - Inventories

Note 6 - Inventories	9 Months Ended
	Sep. 30, 2021
Notes to Financial Statements
Inventory Disclosure [Text Block]	NOTE 6. The following table details the components of inventories (in thousands). September 30, December 31, 2021 2020 Finished goods $ 1,461 $ 1,512 Raw materials 558 236 Packaging 154 130 Inventories $ 2,173 $ 1,878

Note 7 - Property and Equipment

Note 7 - Property and Equipment	9 Months Ended
	Sep. 30, 2021
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	NOTE 7. The following table details the components of property and equipment (amounts in thousands). September 30, December 31 2021 2020 Estimated Useful Lives Land $ 730 $ 730 Furniture and fixtures 276 276 5 - 10 years Plant 10,044 9,377 20 - 40 years, or life of lease Computer and software 1,095 1,060 3 - 5 years Leasehold improvements 1,880 1,880 4 - 15 years, or life of lease Machinery and equipment 16,811 16,402 5 - 15 years Property and equipment, cost 30,836 29,725 Less accumulated depreciation 15,156 13,358 Property and equipment, net $ 15,680 $ 16,367 Amounts payable for property and equipment included in accounts payable of $0.1 million at September 30, 2021, December 31, 2020. not September 30, 2021, December 31, 2020. Involuntary Conversion In 2020, August 2020 September 2020, September 2020, third 2020. three nine September 30, 2021, September 30, 2021, December 31, 2020. September 30, 2021. not

Note 8 - Leases

Note 8 - Leases	9 Months Ended
	Sep. 30, 2021
Notes to Financial Statements
Lessee, Operating and Finance Leases [Text Block]	NOTE 8. The components of lease expense and cash flows from leases (amounts in thousands) follow. Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Finance lease cost: Amortization of right-of use assets, included in cost of goods sold $ 24 $ 20 $ 67 $ 41 Interest on lease liabilities 2 4 8 8 Operating lease cost, included in selling, general and administrative expenses: Fixed leases cost 129 131 387 261 Variable lease cost 37 33 112 48 Short-term lease cost 21 - 60 3 Total lease cost $ 213 $ 188 $ 634 $ 361 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from finance leases $ 2 $ 4 $ 8 $ 8 Operating cash flows from operating leases $ 129 $ 131 $ 387 $ 261 Financing cash flows from finance leases $ 23 $ 20 $ 73 $ 46 As of September 30, 2021, not September 30, 2021, 2021, As of September 30, 2021, not September 30, 2021, Operating Leases Finance Leases Remaining leases terms (in years) 2.1 - 11.4 0.2 - 4.9 Weighted average remaining lease terms (in years) 6.4 2.4 Discount rates 6.3% - 9.0 % 2.8% - 7.3 % Weighted average discount rate 7.7 % 5.1 % Maturities of lease liabilities as of September 30, 2021, Operating Finance Leases Leases 2021 (three months ended December 31, 2021) $ 119 $ 26 2022 548 88 2023 528 57 2024 429 18 2025 439 4 Thereafter 1,028 2 Total lease payments 3,091 195 Amounts representing interest (689 ) (8 ) Present value of lease obligations $ 2,402 $ 187

Note 9 - Debt

Note 9 - Debt	9 Months Ended
	Sep. 30, 2021
Notes to Financial Statements
Debt Disclosure [Text Block]	NOTE 9. We finance certain amounts owed for annual insurance premiums under financing agreements. As of September 30, 2021, February 2022, In October 2019, may two two no October 2021, two no one Due under factoring agreement consists of the following (in thousands). September 30, December 31, 2021 2020 Borrowings outstanding $ 2,026 $ 1,860 Debt issuance costs, net (8 ) (75 ) Due under factoring agreement $ 2,018 $ 1,785 Additional information related to our factoring obligation follows. Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Average borrowings outstanding (in thousands) $ 1,522 $ 1,670 $ 1,324 $ 1,900 Amortization of debt issuance costs (in thousands) $ 23 $ 23 $ 68 $ 68 Fees paid, as a percentage of average outstanding borrowings 2.0 % 1.4 % 5.0 % 6.0 % Interest paid, as a percentage of average outstanding borrowings 1.6 % 1.5 % 5.0 % 5.0 % Long-term debt consists of the following (in thousands). September 30, December 31, 2021 2020 Mortgage promissory note - Dated September 2020. Interest accrues at an annual rate which is the greater of 11.0% 14.3% $20 $26 $ 1,404 $ 1,817 Payroll Protection Program note - Dated April 2020. Interest accrued at an annual rate of 1.0% - 1,792 Equipment notes - Initially recorded in November 2018, in an acquisition, at the present value of future payments using a discount rate of 4.8% 15 37 Equipment note - Dated December 2019. Due in monthly installments through December 2024. Interest accrues at the effective discount rate of 9.3% 28 33 Equipment note - Dated May 2021. Original principal $46. Due in monthly installments through June 2025. Interest accrues at the effective discount rate of 3.6% 36 - Total long term debt, net $ 1,483 $ 3,679 In April 2020, March 2020. December 31 2020, January 2021. 14, In July 2020, September 2020, October 2020, June 2022. September 30, 2021, 14.3%. Future principal maturities of long-term debt outstanding as of September 30, 2021, 2021 (three months ended December 31, 2021) $ 155 2022 1,306 2023 18 2024 19 2025 5 Principal maturities 1,503 Debt issuance costs (20 ) Total long term debt, net $ 1,483

Note 10 - Equity, Share-based C

Note 10 - Equity, Share-based Compensation and Warrants	9 Months Ended
	Sep. 30, 2021
Notes to Financial Statements
Shareholders' Equity and Share-based Payments [Text Block]	NOTE 10. A summary of equity activity follows (in thousands, except share amounts). Shares Preferred Preferred Common Accumulated Series G Common Stock Stock Deficit Equity Balance, December 31, 2020 225 45,238,087 $ 112 $ 322,218 $ (298,910 ) $ 23,420 Common stock awards under equity incentive plans - 29,943 - 250 - 250 Common stock issued to vendor - 6,000 - 3 - 3 Other - - - (3 ) - (3 ) Net income - - - - 591 591 Balance, March 31, 2021 225 45,274,030 112 322,468 (298,319 ) 24,261 Common stock awards under equity incentive plans - 29,643 - 290 - 290 Common stock issued to vendor - 6,000 - 5 - 5 Exercise of common stock warrant - 177,936 - 171 - 171 Other - - - 3 - 3 Net loss - - - - (1,923 ) (1,923 ) Balance, June 30, 2021 225 45,487,609 112 322,937 (300,242 ) 22,807 Common stock awards under equity incentive plans - 38,978 - 287 - 287 Common stock issued to vendor - 6,000 - 5 - 5 Sale of common stock and common stock warrants, net of costs - 3,062,395 - 2,725 - 2,725 Exercise of common stock warrant - 1,500,000 - - - - Conversion of preferred stock into common stock (75 ) 71,174 (37 ) 37 - - Net loss - - - - (2,213 ) (2,213 ) Balance, September 30, 2021 150 50,166,156 $ 75 $ 325,991 $ (302,455 ) $ 23,611 Shares Other Preferred Preferred Common Accumulated Comprehensive Series G Common Stock Stock Deficit Loss Equity Balance, December 31, 2019 225 40,074,483 $ 112 $ 318,811 $ (287,180 ) $ - $ 31,743 Common stock awards under equity incentive plans - 17,534 - 312 - - 312 Net loss - - - - (3,033 ) - (3,033 ) Balance, March 31, 2020 225 40,092,017 112 319,123 (290,213 ) - 29,022 Common stock awards under equity incentive plans - 16,500 - 316 - - 316 Common stock issued to vendors - 31,304 - 36 - - 36 Exercise of common stock warrants - 67,577 - 12 - - 12 Other comprehensive loss - - - - - (48 ) (48 ) Net loss - - - - (3,949 ) - (3,949 ) Balance, June 30, 2020 225 40,207,398 112 319,487 (294,162 ) (48 ) 25,389 Common stock awards under equity incentive plans - 129,404 - 153 - - 153 Sale of common stock, net of costs - 1,635,792 - 657 - - 657 Other comprehensive income - - - - - 48 48 Net loss - - - - (2,774 ) - (2,774 ) Balance, September 30, 2020 225 41,972,594 $ 112 $ 320,297 $ (296,936 ) $ - $ 23,473 RiceBran Technologies Notes to Unaudited Condensed Consolidated Financial Statements Share-based compensation under equity incentive plans, by type of award follows (in thousands). Three Months Ended September 30, 2021 June 30, 2021 March 31, 2021 Common stock, vested at issuance and nonvested at issuance $ 29 $ 32 $ 28 Stock options 35 35 36 Restricted stock units 223 223 186 Compensation expense related to common stock awards issued under equity incentive plans $ 287 $ 290 $ 250 In September 2021, 3. September 2022, September 2023, 5 not may September 13, 2021, 2,307,855 September 13, 2021, September 2021 may Under the terms of the securities purchase agreement related to the September 2021 March 12, 2022. September 13, 2023. During the three September 30, 2021, may March 2020. 3. In the three September 30, 2021, three June 30, 2021, three March 31, 2021, In the three September 30, 2021, three June 30, 2021, three March 31, 2021, RiceBran Technologies Notes to Unaudited Condensed Consolidated Financial Statements A summary of restricted stock unit ("RSU") activity follows. RSU Shares Issued Unrecognized Stock Compensation (in thousands) Weighted Average Expense Period (Years) Nonvested at December 31, 2020 1,495,400 $ 730 1.4 Granted 452,400 412 2.0 Expensed - (186 ) Nonvested at March 31, 2021 1,947,800 956 1.4 Granted 344,040 375 1.0 Vested (450,400 ) - Expensed - (223 ) Nonvested at June 30, 2021 1,841,440 1,108 1.4 Forfeited (2,907 ) (3 ) Expensed - (223 ) Nonvested at September 30, 2021 1,838,533 $ 882 1.1 The shares of common stock subject to the RSUs granted in 2021 two 2021 not As of September 30, 2021, no In the three September 30, 2021, September 30, 2021, In the three June 30, 2021, In the three March 31, 2021, In October 2021,

Note 11 - Income Taxes

Note 11 - Income Taxes	9 Months Ended
	Sep. 30, 2021
Notes to Financial Statements
Income Tax Disclosure [Text Block]	NOTE 11. Our tax expense for the three nine September 30, 2021 2020, no September 30, 2021, not not

Note 12 - Loss Per Share (EPS)

Note 12 - Loss Per Share (EPS)	9 Months Ended
	Sep. 30, 2021
Notes to Financial Statements
Earnings Per Share [Text Block]	NOTE 12. Basic EPS is calculated under the two may not Diluted EPS is computed by dividing the net loss attributable to RiceBran Technologies common shareholders by the weighted average number of common shares outstanding during the period increased by the number of additional common shares that would have been outstanding if the impact of assumed exercises and conversions is dilutive. The dilutive effects of outstanding options, warrants, nonvested shares of common stock and nonvested restricted stock units that vest solely on the basis of a service condition are calculated using the treasury stock method. The dilutive effects of the outstanding preferred stock are calculated using the if-converted method. Below are reconciliations of the numerators and denominators in the EPS. Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 NUMERATOR (in thousands): Denominator for basic and diluted EPS - net loss $ (2,213 ) $ (2,774 ) $ (3,545 ) $ (9,756 ) DENOMINATOR: Weighted average number of shares of shares of common stock outstanding 46,620,039 40,691,824 45,755,871 40,232,289 Weighted average number of shares of common stock underlying vested RSUs 836,803 132,457 562,933 47,577 Denominator for basic and diluted EPS - weighted average number of shares outstanding 47,456,842 40,824,281 46,318,804 40,279,866 No three nine September 30, 2021 2020, three nine September 30, 2021 2020,

Note 13 - Fair Value Measuremen

Note 13 - Fair Value Measurements	9 Months Ended
	Sep. 30, 2021
Notes to Financial Statements
Fair Value Disclosures [Text Block]	NOTE 13. The fair value of cash and cash equivalents, restricted cash, accounts and other receivables and accounts payable approximates their carrying value due to shorter maturities. As of September 30, 2021, 3 September 30, 2021, 3 The following tables summarize the fair values by input hierarchy of items measured at fair value on a recurring basis on our consolidated balance sheets (in thousands): Level 1 Level 2 Level 3 Total Warrant liability (1) $ - $ - $ 647 $ 647 Total liabilities at fair value $ - $ - $ 647 $ 647 The following tables summarize the changes in level 3 three nine September 30, 2021 ( Fair Value as of Beginning of Period Total Realized and Unrealized Gains (Losses) Issuance of New Instruments Net Transfers (Into) Out of Level 3 Fair Value, at End of Period Change in Unrealized Gains (Losses) on Instruments Still Held Warrant liability (1) $ - $ - $ 647 $ - $ 647 $ - Total Level 3 fair value $ - $ - $ 647 $ - $ 647 $ - ( 1 We estimated the fair value of the Warrant using the Black-Scholes value of a 5-year warrant with an exercise price of $1.00 per share.

Note 14 - Commitments and Conti

Note 14 - Commitments and Contingencies	9 Months Ended
	Sep. 30, 2021
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	NOTE 14. PPP Audit Contingency As discussed in Note 9, January 2021. may January 2027, six may 2020 $2 Employment Contracts and Severance Payments In the normal course of business, we periodically enter into employment agreements which incorporate indemnification provisions. While the maximum amount to which we may No We have employment contracts with certain officers and key management that include provisions for potential severance payments in the event of without-cause terminations or terminations under certain circumstances after a change in control. In addition, vesting of outstanding nonvested equity grants would accelerate following a change in control. Legal Matters From time to time, we are involved in litigation incidental to the conduct of our business. These matters may no

Note 15 - Related Party Transac

Note 15 - Related Party Transactions	9 Months Ended
	Sep. 30, 2021
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	NOTE 15. Our director, Ari Gendason, is an employee and senior vice president and chief investment officer of Continental Grain Company ("CGC"). As of the date of this filing, CGC owns approximately 21.2% of our outstanding common stock. We have agreed that in connection with each annual or special meeting of our shareholders at which members of our board of directors are to be elected, or any written consent of our shareholders pursuant to which members of the board of directors are to be elected, CGC shall have the right to designate one nominee to our board of directors.

Note 16 - Failure to Comply wit

Note 16 - Failure to Comply with NASDAQ Listing Requirements	9 Months Ended
	Sep. 30, 2021
Notes to Financial Statements
Failure to Comply with Nasdaq Listing Requirements Disclosure [Text Block]	NOTE 16. On September 15, 2021, 5550 2 5550 2 $1.00. $1.00 10, not 20, 5810 3 180 March 14, 2022, may 180 $1.00

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
New Accounting Pronouncements, Policy [Policy Text Block]	Recent accounting standards not The following discusses the accounting standard(s) not In June 2016, ASU No. 2016 13 Credit Losses (Topic 326 Measurement of Credit Losses on Financial Instruments 2023 January 1, 2023. not Recently adopted accounting standards In August 2020, ASU 2020 06, Debt with Conversion and Other Options (Subtopic 470 20 Contracts in Entity s Own Equity (Subtopic 815 40 815 40 25. 2020 06 January 1, 2021, no

Note 5 - Accounts Receivable _2

Note 5 - Accounts Receivable and Revenues (Tables)	9 Months Ended
	Sep. 30, 2021
Notes Tables
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	Customer A B C D E % of revenues, three months ended September 30, 2021 21 % 9 % 7 % 5 % 2 % % of revenues, three months ended September 30, 2020 - % - % 6 % 12 % 4 % % of revenues, nine months ended September 30, 2021 10 % 11 % 11 % 5 % 2 % % of revenues, nine months ended September 30, 2020 1 % 3 % 11 % 10 % 3 % % of accounts receivable, as of September 30, 2021 15 % 4 % 9 % 8 % 6 % % of accounts receivable, as of December 31, 2020 10 % 7 % 1 % 17 % 10 %
Disaggregation of Revenue [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 United States $ 6,450 $ 4,714 $ 21,867 $ 18,214 Other countries 459 446 1,221 1,179 Revenues $ 6,909 $ 5,160 $ 23,088 $ 19,393

Note 6 - Inventories (Tables)

Note 6 - Inventories (Tables)	9 Months Ended
	Sep. 30, 2021
Notes Tables
Schedule of Inventory, Current [Table Text Block]	September 30, December 31, 2021 2020 Finished goods $ 1,461 $ 1,512 Raw materials 558 236 Packaging 154 130 Inventories $ 2,173 $ 1,878

Note 7 - Property and Equipme_2

Note 7 - Property and Equipment (Tables)	9 Months Ended
	Sep. 30, 2021
Notes Tables
Property, Plant and Equipment [Table Text Block]	September 30, December 31 2021 2020 Estimated Useful Lives Land $ 730 $ 730 Furniture and fixtures 276 276 5 - 10 years Plant 10,044 9,377 20 - 40 years, or life of lease Computer and software 1,095 1,060 3 - 5 years Leasehold improvements 1,880 1,880 4 - 15 years, or life of lease Machinery and equipment 16,811 16,402 5 - 15 years Property and equipment, cost 30,836 29,725 Less accumulated depreciation 15,156 13,358 Property and equipment, net $ 15,680 $ 16,367

Note 8 - Leases (Tables)

Note 8 - Leases (Tables)	9 Months Ended
	Sep. 30, 2021
Notes Tables
Lease, Cost [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Finance lease cost: Amortization of right-of use assets, included in cost of goods sold $ 24 $ 20 $ 67 $ 41 Interest on lease liabilities 2 4 8 8 Operating lease cost, included in selling, general and administrative expenses: Fixed leases cost 129 131 387 261 Variable lease cost 37 33 112 48 Short-term lease cost 21 - 60 3 Total lease cost $ 213 $ 188 $ 634 $ 361 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from finance leases $ 2 $ 4 $ 8 $ 8 Operating cash flows from operating leases $ 129 $ 131 $ 387 $ 261 Financing cash flows from finance leases $ 23 $ 20 $ 73 $ 46
Lessee, Operating and Finance Leases, Remaining Terms and Discount Rates [Table Text Block]	Operating Leases Finance Leases Remaining leases terms (in years) 2.1 - 11.4 0.2 - 4.9 Weighted average remaining lease terms (in years) 6.4 2.4 Discount rates 6.3% - 9.0 % 2.8% - 7.3 % Weighted average discount rate 7.7 % 5.1 %
Lessee, Operating and Finance Lease Liability, Maturity [Table Text Block]	Operating Finance Leases Leases 2021 (three months ended December 31, 2021) $ 119 $ 26 2022 548 88 2023 528 57 2024 429 18 2025 439 4 Thereafter 1,028 2 Total lease payments 3,091 195 Amounts representing interest (689 ) (8 ) Present value of lease obligations $ 2,402 $ 187

Note 9 - Debt (Tables)

Note 9 - Debt (Tables)	9 Months Ended
	Sep. 30, 2021
Notes Tables
Schedule of Debt [Table Text Block]	September 30, December 31, 2021 2020 Borrowings outstanding $ 2,026 $ 1,860 Debt issuance costs, net (8 ) (75 ) Due under factoring agreement $ 2,018 $ 1,785 Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Average borrowings outstanding (in thousands) $ 1,522 $ 1,670 $ 1,324 $ 1,900 Amortization of debt issuance costs (in thousands) $ 23 $ 23 $ 68 $ 68 Fees paid, as a percentage of average outstanding borrowings 2.0 % 1.4 % 5.0 % 6.0 % Interest paid, as a percentage of average outstanding borrowings 1.6 % 1.5 % 5.0 % 5.0 %
Schedule of Long-term Debt Instruments [Table Text Block]	September 30, December 31, 2021 2020 Mortgage promissory note - Dated September 2020. Interest accrues at an annual rate which is the greater of 11.0% 14.3% $20 $26 $ 1,404 $ 1,817 Payroll Protection Program note - Dated April 2020. Interest accrued at an annual rate of 1.0% - 1,792 Equipment notes - Initially recorded in November 2018, in an acquisition, at the present value of future payments using a discount rate of 4.8% 15 37 Equipment note - Dated December 2019. Due in monthly installments through December 2024. Interest accrues at the effective discount rate of 9.3% 28 33 Equipment note - Dated May 2021. Original principal $46. Due in monthly installments through June 2025. Interest accrues at the effective discount rate of 3.6% 36 - Total long term debt, net $ 1,483 $ 3,679
Schedule of Maturities of Long-term Debt [Table Text Block]	2021 (three months ended December 31, 2021) $ 155 2022 1,306 2023 18 2024 19 2025 5 Principal maturities 1,503 Debt issuance costs (20 ) Total long term debt, net $ 1,483

Note 10 - Equity, Share-based_2

Note 10 - Equity, Share-based Compensation and Warrants (Tables)	9 Months Ended
	Sep. 30, 2021
Notes Tables
Schedule of Stockholders Equity [Table Text Block]	Shares Preferred Preferred Common Accumulated Series G Common Stock Stock Deficit Equity Balance, December 31, 2020 225 45,238,087 $ 112 $ 322,218 $ (298,910 ) $ 23,420 Common stock awards under equity incentive plans - 29,943 - 250 - 250 Common stock issued to vendor - 6,000 - 3 - 3 Other - - - (3 ) - (3 ) Net income - - - - 591 591 Balance, March 31, 2021 225 45,274,030 112 322,468 (298,319 ) 24,261 Common stock awards under equity incentive plans - 29,643 - 290 - 290 Common stock issued to vendor - 6,000 - 5 - 5 Exercise of common stock warrant - 177,936 - 171 - 171 Other - - - 3 - 3 Net loss - - - - (1,923 ) (1,923 ) Balance, June 30, 2021 225 45,487,609 112 322,937 (300,242 ) 22,807 Common stock awards under equity incentive plans - 38,978 - 287 - 287 Common stock issued to vendor - 6,000 - 5 - 5 Sale of common stock and common stock warrants, net of costs - 3,062,395 - 2,725 - 2,725 Exercise of common stock warrant - 1,500,000 - - - - Conversion of preferred stock into common stock (75 ) 71,174 (37 ) 37 - - Net loss - - - - (2,213 ) (2,213 ) Balance, September 30, 2021 150 50,166,156 $ 75 $ 325,991 $ (302,455 ) $ 23,611 Shares Other Preferred Preferred Common Accumulated Comprehensive Series G Common Stock Stock Deficit Loss Equity Balance, December 31, 2019 225 40,074,483 $ 112 $ 318,811 $ (287,180 ) $ - $ 31,743 Common stock awards under equity incentive plans - 17,534 - 312 - - 312 Net loss - - - - (3,033 ) - (3,033 ) Balance, March 31, 2020 225 40,092,017 112 319,123 (290,213 ) - 29,022 Common stock awards under equity incentive plans - 16,500 - 316 - - 316 Common stock issued to vendors - 31,304 - 36 - - 36 Exercise of common stock warrants - 67,577 - 12 - - 12 Other comprehensive loss - - - - - (48 ) (48 ) Net loss - - - - (3,949 ) - (3,949 ) Balance, June 30, 2020 225 40,207,398 112 319,487 (294,162 ) (48 ) 25,389 Common stock awards under equity incentive plans - 129,404 - 153 - - 153 Sale of common stock, net of costs - 1,635,792 - 657 - - 657 Other comprehensive income - - - - - 48 48 Net loss - - - - (2,774 ) - (2,774 ) Balance, September 30, 2020 225 41,972,594 $ 112 $ 320,297 $ (296,936 ) $ - $ 23,473
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Three Months Ended September 30, 2021 June 30, 2021 March 31, 2021 Common stock, vested at issuance and nonvested at issuance $ 29 $ 32 $ 28 Stock options 35 35 36 Restricted stock units 223 223 186 Compensation expense related to common stock awards issued under equity incentive plans $ 287 $ 290 $ 250
Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]	RSU Shares Issued Unrecognized Stock Compensation (in thousands) Weighted Average Expense Period (Years) Nonvested at December 31, 2020 1,495,400 $ 730 1.4 Granted 452,400 412 2.0 Expensed - (186 ) Nonvested at March 31, 2021 1,947,800 956 1.4 Granted 344,040 375 1.0 Vested (450,400 ) - Expensed - (223 ) Nonvested at June 30, 2021 1,841,440 1,108 1.4 Forfeited (2,907 ) (3 ) Expensed - (223 ) Nonvested at September 30, 2021 1,838,533 $ 882 1.1

Note 12 - Loss Per Share (EPS)

Note 12 - Loss Per Share (EPS) (Tables)	9 Months Ended
	Sep. 30, 2021
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 NUMERATOR (in thousands): Denominator for basic and diluted EPS - net loss $ (2,213 ) $ (2,774 ) $ (3,545 ) $ (9,756 ) DENOMINATOR: Weighted average number of shares of shares of common stock outstanding 46,620,039 40,691,824 45,755,871 40,232,289 Weighted average number of shares of common stock underlying vested RSUs 836,803 132,457 562,933 47,577 Denominator for basic and diluted EPS - weighted average number of shares outstanding 47,456,842 40,824,281 46,318,804 40,279,866

Note 13 - Fair Value Measurem_2

Note 13 - Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2021
Notes Tables
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]	Level 1 Level 2 Level 3 Total Warrant liability (1) $ - $ - $ 647 $ 647 Total liabilities at fair value $ - $ - $ 647 $ 647
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Fair Value as of Beginning of Period Total Realized and Unrealized Gains (Losses) Issuance of New Instruments Net Transfers (Into) Out of Level 3 Fair Value, at End of Period Change in Unrealized Gains (Losses) on Instruments Still Held Warrant liability (1) $ - $ - $ 647 $ - $ 647 $ - Total Level 3 fair value $ - $ - $ 647 $ - $ 647 $ -

Note 2 - Business (Details Text

Note 2 - Business (Details Textual) - Stabilized Rice Bran (SRB) [Member]	9 Months Ended
	Sep. 30, 2021
Number of Manufacturing and Distribution Locations	4
CALIFORNIA
Number of Manufacturing and Distribution Locations	2
LOUISIANA
Number of Manufacturing and Distribution Locations	1
ARKANSAS
Number of Reporting Units	1
Number of Operating Segments	1

Note 4 - Cash and Cash Equiva_2

Note 4 - Cash and Cash Equivalents (Details Textual) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Cash and Cash Equivalents, at Carrying Value, Ending Balance	$ 6,188	$ 5,263
Money Market Funds [Member]
Cash and Cash Equivalents, at Carrying Value, Ending Balance	$ 4,500

Note 5 - Accounts Receivable _3

Note 5 - Accounts Receivable and Revenues - Revenues and Accounts Receivable from Significant Customers (Details) - Customer Concentration Risk [Member]	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Revenue Benchmark [Member] | Customer A [Member]
Concentration risk, percentage	21.00%	0.00%	10.00%	1.00%
Revenue Benchmark [Member] | Customer B [Member]
Concentration risk, percentage	9.00%	0.00%	11.00%	3.00%
Revenue Benchmark [Member] | Customer C [Member]
Concentration risk, percentage	7.00%	6.00%	11.00%	11.00%
Revenue Benchmark [Member] | Customer D [Member]
Concentration risk, percentage	5.00%	12.00%	5.00%	10.00%
Revenue Benchmark [Member] | Customer E [Member]
Concentration risk, percentage	2.00%	4.00%	2.00%	3.00%
Accounts Receivable [Member] | Customer A [Member]
Concentration risk, percentage			15.00%		10.00%
Accounts Receivable [Member] | Customer B [Member]
Concentration risk, percentage			4.00%		7.00%
Accounts Receivable [Member] | Customer C [Member]
Concentration risk, percentage			9.00%		1.00%
Accounts Receivable [Member] | Customer D [Member]
Concentration risk, percentage			8.00%		17.00%
Accounts Receivable [Member] | Customer E [Member]
Concentration risk, percentage			6.00%		10.00%

Note 5 - Accounts Receivable _4

Note 5 - Accounts Receivable and Revenues - Revenues by Product Line (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Revenues	$ 6,909	$ 5,160	$ 23,088	$ 19,393
UNITED STATES
Revenues	6,450	4,714	21,867	18,214
Other Countries [Member]
Revenues	$ 459	$ 446	$ 1,221	$ 1,179

Note 6 - Inventories - Componen

Note 6 - Inventories - Components of Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Finished goods	$ 1,461	$ 1,512
Raw materials	558	236
Packaging	154	130
Inventories	$ 2,173	$ 1,878

Note 7 - Property and Equipme_3

Note 7 - Property and Equipment (Details Textual) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Construction Payable, Current		$ 100		$ 100		$ 300
Construction in Progress, Gross		800		800		600
Unusual or Infrequent Item, or Both, Loss, Gross			$ 100
Unusual or Infrequent Item or Both Other Costs	$ 100
Charges Deductible Under Insurance Policy	100
Unusual or Infrequent Item, or Both, Insurance Proceeds	300
Insurance Settlement Accrued Receivable	700	100	$ 700	100	$ 700	$ 700
Proceeds from Insurance Settlement, Investing Activities		$ 400		$ 638	$ 250
Natural Disasters and Other Casualty Events [Member]
Unusual or Infrequent Item, or Both, Loss, Gross	$ 900

Note 7 - Property and Equipme_4

Note 7 - Property and Equipment - Property, Plant and Equipment (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Property, plant, and equipment gross	$ 30,836	$ 29,725
Property, plant, and equipment accumulated depreciation	15,156	13,358
Property and equipment, net	15,680	16,367
Land [Member]
Property, plant, and equipment gross	730	730
Furniture and Fixtures [Member]
Property, plant, and equipment gross	$ 276	276
Furniture and Fixtures [Member] | Minimum [Member]
Estimated useful lives (Year)	5 years
Furniture and Fixtures [Member] | Maximum [Member]
Estimated useful lives (Year)	10 years
Plant [Member]
Property, plant, and equipment gross	$ 10,044	9,377
Plant [Member] | Minimum [Member]
Estimated useful lives (Year)	20 years
Plant [Member] | Maximum [Member]
Estimated useful lives (Year)	40 years
Computer and Software [Member]
Property, plant, and equipment gross	$ 1,095	1,060
Computer and Software [Member] | Minimum [Member]
Estimated useful lives (Year)	3 years
Computer and Software [Member] | Maximum [Member]
Estimated useful lives (Year)	5 years
Leasehold Improvements [Member]
Property, plant, and equipment gross	$ 1,880	1,880
Leasehold Improvements [Member] | Minimum [Member]
Estimated useful lives (Year)	4 years
Leasehold Improvements [Member] | Maximum [Member]
Estimated useful lives (Year)	15 years
Machinery and Equipment [Member]
Property, plant, and equipment gross	$ 16,811	$ 16,402
Machinery and Equipment [Member] | Minimum [Member]
Estimated useful lives (Year)	5 years
Machinery and Equipment [Member] | Maximum [Member]
Estimated useful lives (Year)	15 years

Note 8 - Leases (Details Textua

Note 8 - Leases (Details Textual) $ in Millions	Sep. 30, 2021USD ($)
Finance Lease, Right-of-Use Asset, after Accumulated Amortization, Total	$ 0.2
Finance Lease, Right-of-Use Asset, before Accumulated Amortization	0.5
Property and Equipment [Member]
Finance Lease, Right-of-Use Asset, after Accumulated Amortization, Total	$ 0.1

Note 8 - Leases - Components of

Note 8 - Leases - Components of Lease Expense and Cash Flows from Leases (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Amortization of right-of use assets, included in cost of goods sold	$ 24	$ 20	$ 67	$ 41
Interest on lease liabilities	2	4	8	8
Fixed leases cost	129	131	387	261
Variable lease cost	37	33	112	48
Short-term lease cost	21	0	60	3
Total lease cost	213	188	634	361
Operating cash flows from finance leases	2	4	8	8
Operating cash flows from operating leases	129	131	387	261
Financing cash flows from finance leases	$ 23	$ 20	$ 73	$ 46

Note 8 - Leases - Remaining Ter

Note 8 - Leases - Remaining Terms and Discount Rates (Details)	Sep. 30, 2021
Weighted average remaining lease terms (in years), operating leases (Year)	6 years 8 months 12 days
Weighted average remaining lease terms (in years), finance leases (Year)	2 years 6 months
Weighted average discount rate, operating leases	7.70%
Weighted average discount rate, finance leases	5.20%
Minimum [Member]
Remaining leases terms (in years), operating leases (Year)	2 years 1 month 6 days
Remaining leases terms (in years), finance leases (Year)	2 months 12 days
Discount rates, operating leases	6.30%
Discount rates, finance leases	2.80%
Maximum [Member]
Remaining leases terms (in years), operating leases (Year)	11 years 4 months 24 days
Remaining leases terms (in years), finance leases (Year)	4 years 10 months 24 days
Discount rates, operating leases	9.00%
Discount rates, finance leases	7.30%

Note 8 - Leases - Maturities of

Note 8 - Leases - Maturities of Lease Liabilities (Details) $ in Thousands	Sep. 30, 2021USD ($)
2021, operating leases	$ 119
2021, finance leases	26
2022, operating leases	548
2022, finance leases	88
2023, operating leases	528
2023, finance leases	57
2024, operating leases	429
2024, finance leases	18
2025, operating leases	439
2025, finance leases	4
Thereafter, operating leases	1,028
Thereafter, finance leases	2
Total lease payments, operating leases	3,091
Total lease payments, finance leases	195
Amounts representing interest, operating leases	(689)
Amounts representing interest, finance leases	(8)
Present value of lease obligations, operating leases	2,402
Present value of lease obligations, finance leases	$ 187

Note 9 - Debt (Details Textual)

Note 9 - Debt (Details Textual) - USD ($) $ in Thousands	1 Months Ended				9 Months Ended	10 Months Ended	12 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Sep. 30, 2020	Jul. 31, 2020	Sep. 30, 2021	Oct. 31, 2019	Dec. 31, 2020	Apr. 30, 2020
Long-term Debt, Total					$ 1,483		$ 3,679
Factoring Agreement [Member] | Line of Credit [Member]
Line of Credit Facility, Maximum Borrowing Capacity						$ 7,000
Debt Instrument, Term (Year)	1 year					2 years
Debt Instrument, Fee Amount						$ 200
Line of Credit Facility, Funding Fee, Percentage Above Prime Rate						0.50%
Line of Credit Facility, Funding Fee, Minimum Percentage						5.50%
Paycheck Protection Program CARES Act [Member]
Debt Instrument, Interest Rate, Stated Percentage							1.00%	1.00%
Long-term Debt, Total					$ 0		$ 1,792	$ 1,800
Mortgage Agreement [Member]
Debt Instrument, Interest Rate, Stated Percentage				14.30%	14.30%		14.30%
Long-term Debt, Total					$ 1,404		$ 1,817
Proceeds from Issuance of Long-term Debt, Total		$ 1,000	$ 1,000
Debt Instrument, Basis Spread on Variable Rate					11.00%		11.00%
Debt Instrument, Facility Fee, Percentage of Each Advance				1.00%
Mortgage Agreement [Member] | Prime Rate [Member]
Debt Instrument, Basis Spread on Variable Rate				11.00%
Finance Agreements for Annual Insurance Premiums [Member]
Debt Instrument, Interest Rate, Stated Percentage					3.70%

Note 9 - Debt - Due Under Facto

Note 9 - Debt - Due Under Factoring Agreement (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Debt issuance costs	$ (20)		$ (20)
Due under factoring agreement	2,018		2,018		$ 1,785
Factoring Agreement [Member] | Line of Credit [Member]
Borrowings outstanding	2,026		2,026		1,860
Debt issuance costs	(8)		(8)		(75)
Due under factoring agreement	2,018		2,018		$ 1,785
Average borrowings outstanding (in thousands)	1,522	$ 1,670	1,324	$ 1,900
Amortization of debt issuance costs (in thousands)	$ 23	$ 23	$ 68	$ 68
Fees paid, as a percentage of average outstanding borrowings	2.00%	1.40%	5.00%	6.00%
Interest paid, as a percentage of average outstanding borrowings	1.60%	1.50%	5.00%	5.00%

Note 9 - Debt - Long-term Debt

Note 9 - Debt - Long-term Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020	Apr. 30, 2020
Total long term debt, net	$ 1,483	$ 3,679
Mortgage Agreement [Member]
Total long term debt, net	1,404	1,817
Paycheck Protection Program CARES Act [Member]
Total long term debt, net	0	1,792	$ 1,800
Equipment Notes, November 2018 [Member] | Notes Payable, Other Payables [Member]
Total long term debt, net	15	37
Equipment Notes, December 2019 [Member] | Notes Payable, Other Payables [Member]
Total long term debt, net	28	33
Equipment Notes, May 2021 [Member] | Notes Payable, Other Payables [Member]
Total long term debt, net	$ 36	$ 0

Note 9 - Debt - Long-term Deb_2

Note 9 - Debt - Long-term Debt (Details) (Parentheticals) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020	Jul. 31, 2020	Apr. 30, 2020
Issuance costs	$ 20
Mortgage Agreement [Member]
Interest rate	14.30%	14.30%	14.30%
Interest rate, variable	11.00%	11.00%
Issuance costs	$ 20	$ 26
Paycheck Protection Program CARES Act [Member]
Interest rate		1.00%		1.00%
Equipment Notes, November 2018 [Member] | Notes Payable, Other Payables [Member]
Interest rate	4.80%	4.80%
Equipment Notes, December 2019 [Member] | Notes Payable, Other Payables [Member]
Interest rate	9.30%	9.30%
Equipment Notes, May 2021 [Member] | Notes Payable, Other Payables [Member]
Interest rate	3.60%

Note 9 - Debt - Future Principa

Note 9 - Debt - Future Principal Maturities of Long-term Debt Outstanding (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
2021 (three months ended December 31, 2021)	$ 155
2022	1,306
2023	18
2024	19
2025	5
Principal maturities	1,503
Debt issuance costs	(20)
Total long term debt, net	$ 1,483	$ 3,679

Note 10 - Equity, Share-based_3

Note 10 - Equity, Share-based Compensation and Warrants (Details Textual) - USD ($) $ / shares in Units, $ in Millions	Sep. 13, 2021	Oct. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2021	Mar. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Total (in shares)			1,834	8,216	18,905
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price (in dollars per share)			$ 1.23	$ 1.90	$ 11.54
Share-based Compensation Arrangement By Share-based Payment Award Options Forfeitures and Expirations, Weighted Average Remaining Contractual Term (Year)			8 years 6 months	8 years 6 months	7 years 6 months
Class of Warrant or Right, Warrants Expired During Period (in shares)					25,000
Class of Warrant or Right, Expired, Exercise Price (in dollars per share)					$ 5.25
Deferred Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)			1,180,843			1,180,843
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares)						836,803
Employees [Member]
Shares Issued, Price Per Share (in dollars per share)			$ 0.75	$ 1.09	$ 0.94	$ 0.75
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture, Total (in shares)			38,978	29,643	29,943
The Warrant [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)	2,307,693
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 1
Class of Warrant or Right, Change in Exercise Price, Maximum Percentage of Five-day Volume Weighted Average Common Stock	110.00%
Warrants and Rights Outstanding	$ 0.6
Prefunded Warrant [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)	2,307,855		807,638			807,638
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 0.0001
Class of Warrant or Right, Exercise Price, Prefunded (in dollars per share)	$ 0.6499
Stock Issued During Period, Cashless Exercise Of Warrants Shares (in shares)			1,500,000
Class of Warrant or Right, Exercised During Period (in shares)			1,500,427
Prefunded Warrant [Member] | Subsequent Event [Member]
Stock Issued During Period, Cashless Exercise Of Warrants Shares (in shares)		807,498
Class of Warrant or Right, Exercised During Period (in shares)		807,638
Cash Exercised Warrants [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)				$ 0.96
Stock Issued During Period, Shares, Warrants Exercised (in shares)				177,936
Offering Pursuant to Shelf Registration Statement [Member]
Stock Issued During Period, Shares, New Issues (in shares)	2,307,500
Proceeds from Issuance or Sale of Equity, Total	$ 2.8
Payments of Stock Issuance Costs	$ 0.2
At-the-market Offering Program [Member]
Stock Issued During Period, Shares, New Issues (in shares)			754,895
Payments of Stock Issuance Costs			$ 0.1
Shares Issued, Price Per Share (in dollars per share)			$ 0.80			$ 0.80
Proceeds from Issuance of Common Stock			$ 0.5
Equity Offering, Maximum Offering Amount							$ 6

Note 10 - Equity, Share-based_4

Note 10 - Equity, Share-based Compensation and Warrants - Stockholders Equity (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020
Balance (in shares)			45,238,087				45,238,087
Balance	$ 22,807	$ 24,261	$ 23,420	$ 25,389	$ 29,022	$ 31,743	$ 23,420	$ 31,743
Common stock awards under equity incentive plans	287	290	250	153	316	312
Common stock issued to vendor	5	5	3		36
Other		3	(3)
Net loss	(2,213)	(1,923)	591	(2,774)	(3,949)	(3,033)	(3,545)	(9,756)
Exercise of common stock warrant	0	171			12
Sale of common stock and common stock warrants, net of costs	2,725
Conversion of preferred stock into common stock	0
Other comprehensive income (loss)	$ 0			48	(48)		$ 0	0
Sale of common stock, net of costs				657
Balance (in shares)	50,166,156						50,166,156
Balance	$ 23,611	22,807	24,261	23,473	25,389	29,022	$ 23,611	23,473
Preferred Stock [Member]
Balance	112	112	112	112	112	112	112	112
Common stock awards under equity incentive plans	0	0	0	0	0	0
Common stock issued to vendor	0	0	0		0
Other		0	0
Net loss	0	0	0	0	0	0
Exercise of common stock warrant	0	0			0
Sale of common stock and common stock warrants, net of costs	0
Conversion of preferred stock into common stock	(37)
Other comprehensive income (loss)				0	0
Sale of common stock, net of costs				0
Balance	$ 75	$ 112	$ 112	$ 112	$ 112	$ 112	$ 75	$ 112
Preferred Stock [Member] | Series G Preferred Stock [Member]
Balance (in shares)	225	225	225	225	225	225	225	225
Common stock awards under equity incentive plans (in shares)	0	0	0	0	0	0
Common stock issued to vendor (in shares)	0	0	0		0
Exercise of common stock warrant (in shares)	0	0			0
Sale of common stock and common stock warrants, net of costs (in shares)	0
Conversion of preferred stock into common stock (in shares)	(75)
Sale of common stock, net of costs (in shares)				0
Balance (in shares)	150	225	225	225	225	225	150	225
Common Stock [Member]
Balance (in shares)	45,487,609	45,274,030	45,238,087	40,207,398	40,092,017	40,074,483	45,238,087	40,074,483
Balance	$ 322,937	$ 322,468	$ 322,218	$ 319,487	$ 319,123	$ 318,811	$ 322,218	$ 318,811
Common stock awards under equity incentive plans (in shares)	38,978	29,643	29,943	129,404	16,500	17,534
Common stock awards under equity incentive plans	$ 287	$ 290	$ 250	$ 153	$ 316	$ 312
Common stock issued to vendor (in shares)	6,000	6,000	6,000		31,304
Common stock issued to vendor	$ 5	$ 5	$ 3		$ 36
Other		3	(3)
Net loss	$ 0	$ 0	$ 0	0	$ 0	$ 0
Exercise of common stock warrant (in shares)	1,500,000	177,936			67,577
Exercise of common stock warrant	$ 0	$ 171			$ 12
Sale of common stock and common stock warrants, net of costs (in shares)	3,062,395
Sale of common stock and common stock warrants, net of costs	$ 2,725
Conversion of preferred stock into common stock (in shares)	71,174
Conversion of preferred stock into common stock	$ 37
Other comprehensive income (loss)				$ 0	$ 0
Sale of common stock, net of costs (in shares)				1,635,792
Sale of common stock, net of costs				$ 657
Balance (in shares)	50,166,156	45,487,609	45,274,030	41,972,594	40,207,398	40,092,017	50,166,156	41,972,594
Balance	$ 325,991	$ 322,937	$ 322,468	$ 320,297	$ 319,487	$ 319,123	$ 325,991	$ 320,297
Retained Earnings [Member]
Balance	(300,242)	(298,319)	(298,910)	(294,162)	(290,213)	(287,180)	(298,910)	(287,180)
Common stock awards under equity incentive plans	0	0	0	0	0	0
Common stock issued to vendor	0	0	0		0
Other		0	0
Net loss	(2,213)	(1,923)	591	(2,774)	(3,949)	(3,033)
Exercise of common stock warrant	0	0			0
Sale of common stock and common stock warrants, net of costs	0
Conversion of preferred stock into common stock	0
Other comprehensive income (loss)				0	0
Sale of common stock, net of costs				0
Balance	$ (302,455)	$ (300,242)	$ (298,319)	(296,936)	(294,162)	(290,213)	$ (302,455)	(296,936)
AOCI Attributable to Parent [Member]
Balance				(48)	0	0		0
Common stock awards under equity incentive plans				0	0	0
Common stock issued to vendor					0
Net loss				0	0	0
Exercise of common stock warrant					0
Other comprehensive income (loss)				48	(48)
Sale of common stock, net of costs				0
Balance				$ 0	$ (48)	$ 0		$ 0

Note 10 - Equity, Share-based_5

Note 10 - Equity, Share-based Compensation and Warrants - Share-based Compensation Expenses Related to Employees and Directors (Details) - The 2014 Equity Incentive Plan [Member] - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021
Compensation expense related to common stock awards issued under equity incentive plans	$ 287	$ 290	$ 250
Common Stock, Vested at Issuance and Nonvested at Issuance [Member]
Compensation expense related to common stock awards issued under equity incentive plans	29	32	28
Share-based Payment Arrangement, Option [Member]
Compensation expense related to common stock awards issued under equity incentive plans	35	35	36
Restricted Stock Units (RSUs) [Member]
Compensation expense related to common stock awards issued under equity incentive plans	$ 223	$ 223	$ 186

Note 10 - Equity, Share-based_6

Note 10 - Equity, Share-based Compensation and Warrants - Restricted Stock Unit Activity (Details) - Restricted Stock Units (RSUs) [Member] - USD ($) $ in Thousands	3 Months Ended				9 Months Ended	12 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021		Sep. 30, 2021	Dec. 31, 2020
Nonvested, shares issued (in shares)	1,841,440	1,947,800	1,495,400		1,495,400
Nonvested, unrecognized stock compensation	$ 1,108	$ 956	$ 730		$ 730
Nonvested, weighted average expense period (Year)	1 year 1 month 6 days	1 year 4 months 24 days	1 year 4 months 24 days			1 year 4 months 24 days
Granted, nonvested, shares issued (in shares)		344,040	452,400
Granted, unrecognized stock compensation		$ 375	$ 412
Granted, weighted average expense period (Year)		1 year	2 years
Expensed, unrecognized stock compensation	$ (223)	$ (223)	$ (186)	[1]
Vested, shares (in shares)		(450,400)
Forfeited, shares (in shares)	(2,907)
Forfeited, unrecognized stock compensation	$ (3)				$ (3)
Nonvested, shares issued (in shares)	1,838,533	1,841,440	1,947,800		1,838,533	1,495,400
Nonvested, unrecognized stock compensation	$ 882	$ 1,108	$ 956		$ 882	$ 730
[1]	We expensed $0.1 million related to recognition of the unrecognized compensation associated with the cancelled RSU shares in the three months ended March 31, 2020.

Note 12 - Loss Per Share (EPS_2

Note 12 - Loss Per Share (EPS) -EPS Compensations (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Denominator for basic and diluted EPS - net loss	$ (2,213)	$ (2,774)	$ (3,545)	$ (9,756)
Weighted average number of shares of shares of common stock outstanding (in shares)	46,620,039	40,691,824	45,755,871	40,232,289
Weighted average number of shares of common stock underlying vested RSUs (in shares)	836,803	132,457	562,933	47,577
Denominator for basic and diluted EPS - weighted average number of shares outstanding (in shares)	47,456,842	40,824,281	46,318,804	40,279,866

Note 13 - Fair Value Measurem_3

Note 13 - Fair Value Measurements (Details Textual) - Fair Value, Recurring [Member] - Fair Value, Inputs, Level 3 [Member] $ in Millions	Sep. 30, 2021USD ($)
Operating Lease, Fair Value In Excess Of Carrying Amount	$ 0.3
Warrants and Rights Outstanding, Term (Year)	5 years
Measurement Input, Exercise Price [Member]
Warrants and Rights Outstanding, Measurement Input	1

Note 13 - Fair Value Measurem_4

Note 13 - Fair Value Measurements - Fair Value of Liabilities on Recurring Basis (Details) - Fair Value, Recurring [Member] $ in Thousands	Sep. 30, 2021USD ($)
Warrant liability (1)	$ 647	[1]
Total liabilities at fair value	647
Fair Value, Inputs, Level 1 [Member]
Warrant liability (1)	0	[1]
Total liabilities at fair value	0
Fair Value, Inputs, Level 2 [Member]
Warrant liability (1)	0	[1]
Total liabilities at fair value	0
Fair Value, Inputs, Level 3 [Member]
Warrant liability (1)	647	[1]
Total liabilities at fair value	$ 647
[1]	We estimated the fair value of the Warrant using the Black-Scholes value of a 5-year warrant with an exercise price of $1.00 per share.

Note 13 - Fair Value Measurem_5

Note 13 - Fair Value Measurements - Changes in Level 3 Items Measured at Fair Value (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2021USD ($)
Fair value as of beginning of period	$ 0
Total realized and unrealized gains (losses)	0
Issuance of new instruments	647
Net transfers (into) out of level 3	0
Fair value at end of period	647
Change in unrealized gains (losses) on instruments still held	0
Derivative Financial Instruments, Liabilities [Member]
Fair value as of beginning of period	0	[1]
Total realized and unrealized gains (losses)	0	[1]
Issuance of new instruments	647	[1]
Net transfers (into) out of level 3	0	[1]
Fair value at end of period	647	[1]
Change in unrealized gains (losses) on instruments still held	$ 0	[1]
[1]	We estimated the fair value of the Warrant using the Black-Scholes value of a 5-year warrant with an exercise price of $1.00 per share.

Note 15 - Related Party Trans_2

Note 15 - Related Party Transactions (Details Textual) - Continental Grain Company [Member]	9 Months Ended
	Sep. 30, 2021
Related Party, Right to Designate to Board of Directors, Number of Nominees	1
RiceBran Technologies [Member]
Ownership Percentage	21.20%